Patients on Alzheimer’s drug Leqembi see benefits over three years, Eisai study says

[ad_1]

The study results on Leqembi, which Eisai shares with Biogen, also found that Alzheimer's patients who take the therapy get worse after they stop treatment.

[ad_2]

Source link